
Motley Fool's Stock Advisor team recently unveiled its list of 10 top stock picks for potential significant returns, notably excluding Hims & Hers (NYSE: HIMS) from this high-conviction selection despite The Motley Fool holding a general position in the company. The advisory service highlighted its historical outperformance, with an average return of 1,046% versus the S&P 500's 181%, to underscore the potential of its current top recommendations. This indicates that while HIMS may be a recommended stock, it is not considered among the highest growth opportunities by this specific advisory service at this time.
A recent report from The Motley Fool indicates that its Stock Advisor analyst team has excluded Hims & Hers Health (HIMS) from its list of the '10 best stocks to buy now.' This is a notable development, as the advisory service touts its historical market outperformance, citing past successful recommendations like Netflix and Nvidia to underscore the high-conviction nature of its top 10 selections. The exclusion implies that while HIMS may be held by The Motley Fool's corporate entity and some of its analysts, the Stock Advisor team does not currently rank it among its highest-potential opportunities for significant near-term returns. The negative sentiment score of -0.3 specifically for HIMS reinforces this view, suggesting a cautious stance from this particular analyst team despite the firm's broader, disclosed position in the stock. The article frames this as a signal for investors to consider other, potentially more lucrative, opportunities identified by the service.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment